Business Context and Reporting Period
This Form 8-K Current Report was filed by Advanced Energy Industries, Inc. on January 31, 2005. The report discloses the entry into a material definitive agreement regarding executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on equity-based compensation awards rather than financial performance results.
Material Changes and Executive Compensation
On January 31, 2005, the Company awarded stock options and restricted stock units (RSUs) to five executive officers pursuant to a compensation structure approved in December 2004. The awards are detailed below:
| Executive Officer | Stock Options | Restricted Stock Units |
|---|---|---|
| Douglas Schatz | 92,700 | 26,350 |
| Charles Rhoades | 35,650 | 10,000 |
| Michael El-Hillow | 33,900 | 9,550 |
| Linda Capuano | 27,200 | 7,650 |
| James Guilmart | 10,000 | 1,500 |
Terms of Awards:
- Exercise Price: Stock options have an exercise price of $7.15 per share, reflecting the closing price on the Nasdaq National Market on the grant date.
- Option Vesting: 25% of underlying shares vest annually on each anniversary of the grant date, becoming fully vested on the fourth anniversary.
- RSU Vesting: 10% vests on the first anniversary, 20% on the second, 30% on the third, and the remaining 40% on the fourth anniversary.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on future performance, or specific risk factors beyond the standard disclosure of the compensation plan amendment. The report notes that Amendment No. 1 to the 2003 Stock Option Plan was adopted by the Board of Directors on January 31, 2005.
Key Facts for Investor Verification
- Verify the total number of shares authorized under the 2003 Stock Option Plan to assess the impact of these new grants on the share pool.
- Confirm the current market price of the stock relative to the $7.15 exercise price to evaluate the intrinsic value of the options.
- Review the filed exhibits (10.1, 10.2, 10.3) for specific performance conditions or clawback provisions not detailed in the summary.
- Monitor future filings for the actual vesting schedule execution and potential dilution effects.